LTGO · Latigo Biotherapeutics, Inc. · Off Exchange
$15.26
+0.24 (+1.60%)
At close · Oct 26
Return incl. dividend (before tax)
Going-concern doubt
— cleared Sep 3, 2026
The latest filing states the doubt was alleviated.
“Accordingly, the prior substantial doubt about the Company's ability to continue as a going concern has been alleviated.”View the 10-Q filed Sep 3, 2026
Market Cap
$954.38M
Shares
66.30M
Volume · Oct 26
165.33K
Avg daily vol (56 sessions)
349.92K
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-09-21 | 546,854 | 143,305 | 690,159 | 41.5% |
| 2026-09-14 | 485,769 | 422,025 | 907,794 | 33.1% |
| 2026-09-07 | 358,297 | 85,881 | 444,178 | 50.8% |
| 2026-08-31 | 300,911 | 122,113 | 423,024 | 39.8% |
| 2026-08-24 | 330,466 | 134,675 | 465,141 | 48.0% |
| 2026-08-17 | 342,621 | 67,176 | 409,797 | 46.4% |
| 2026-08-10 | 695,882 | 229,604 | 925,486 | 57.1% |
| 2026-08-03 | 997,147 | 209,266 | 1,206,413 | 36.5% |
Showing 1–8 of 8 weeks